A current global challenge where vaccination can play a critical role is mpox.
Our latest white paper explores intradermal vaccination—a promising, dose-sparing solution that could revolutionize mpox immunization and ensure long-term protection.
What’s inside our latest white paper?
✔️ Challenges with current mpox vaccine uptake methods
✔️ How intradermal vaccination boosts simplifies large-scale vaccination efforts during outbreaks like mpox
✔️ Challenges with current mpox vaccine uptake methods
✔️ How intradermal vaccination boosts simplifies large-scale vaccination efforts during outbreaks like mpox
✔️ How intradermal vaccination enables dose-sparing strategies to protect more people in areas with limited vaccine supply
Read our white paper here